Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

Company Overview

Development Stage

About the Company

[Summary] 专注小分子创新靶向药研发

壹瑞医药成立于2018年,是一家专注小分子创新靶向药研发的Biotech企业,致力于通过科学立项、低成本、高效率、有效风控等研发策略进行源头创新。公司以自主研发为主导,适应症覆盖自身免疫性疾病、糖尿病并发症、慢性炎症性疾病等领域。在药物靶点、适应症选择、给药方式以及治疗人群等方面均开展差异化布局,努力为全球数亿患者未被满足的临床需求提供新的一线用药。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

壹瑞医药 Financing History (4 rounds)

Manage
A+轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 数千万人民币
  • Investor: 泰鲲基金,天峰资本,胜辉资...

壹瑞医药 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

壹瑞医药 Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 1,591.23万(元)
Legal Representative: 沈陶
Date Established:
Credit Code: 91330101MA2CCGTEXJ
Registered Address: 浙江省杭州经济技术开发区下沙街道福城路291号和达药谷中心2-201-1、2-201-2、2-201-9、2-201-10室

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates